Oncology

Discover our initiatives in various therapeutic areas

Fulvestrant SPC

Fulvestrant SPC® is indicated for the treatment of breast cancer.

Strength:

250 mg/5 ml

Dosage Form:

Pre-filled syringe

Active ingredient:

Fulvestrant

Cabazitaxel SPC

Cabazitaxel SPC® is indicated for the treatment of adult patients with metastatic castration resistant prostate cancer (mCRPC).

Strength:

60 mg/1.5 ml

Dosage Form:

Vial for injection

Active ingredient:

Cabazitaxel

Erlotinib SPC

Erlotinib SPC® is indicated for the treatment of Non-Small Cell Lung and Pancreatic Cancers.

Strength:

100 mg 150 mg

Dosage Form:

Film-Coated Tablets

Active ingredient:

Erlotinib Hydrochloride

Pemetrexed SPC

Pemetrexed SPC® is indicated for the treatment of lung cancer.

Strength:

500 mg

Dosage Form:

Vial for injection

Active ingredient:

Pemetrexed

Abiraterone Acetate SPC

Abiratrone Acetate SPC® is indicated for the treatment of prostate cancer.

Strength:

250 mg 500 mg

Dosage Form:

Film-Coated Tablets

Active ingredient:

Abiraterone Acetate

Docetaxel SPC

Docetaxel SPC® is used for the treatment of breast, non‐small cell lung, prostate, gastric or head and neck cancers.

Strength:

80 mg/4ml

Dosage Form:

Vial for injection

Active ingredient:

Docetaxel

Capecitabine SPC

Capecitabine SPC® is used in the treatment of colon, rectal, gastric, or breast cancers.

Strength:

150 mg 500 mg

Dosage Form:

Film-Coated Tablets

Active ingredient:

Capecitabine